Global Cholesterol Lowering Biologic Drugs Market Outlook 2022
SKU ID : QYR-19624195 | Publishing Date : 30-Nov-2021 | No. of pages : 92
The cholesterol lowering biologics drug market is expected to boom owing to the number of population with high cholesterol levels, sedentary lifestyle and increasing research developments. According to the Indian Council of Medical Research, at least three-fourth of the country’s population has dyslipidemia, a condition where the individual has abnormal levels of triglycerides or cholesterol. The risk factors are obesity, hypertension poor lifestyle habits and diabetes. Moreover, the demand for biologics is driven by the dramatic shift in production technology and an expansion of targeted diseases.
The global Cholesterol Lowering Biologic Drugs market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Cholesterol Lowering Biologic Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cholesterol Lowering Biologic Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Cholesterol Lowering Biologic Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Oral
Injectable
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Amgen
Regeneron Pharmaceuticals
Alnylam Pharmaceuticals
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region